Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 508

1.

Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders.

Barrowclough C, Haddock G, Tarrier N, Lewis SW, Moring J, O'Brien R, Schofield N, McGovern J.

Am J Psychiatry. 2001 Oct;158(10):1706-13.

PMID:
11579006
2.

Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial.

Barrowclough C, Haddock G, Wykes T, Beardmore R, Conrod P, Craig T, Davies L, Dunn G, Eisner E, Lewis S, Moring J, Steel C, Tarrier N.

BMJ. 2010 Nov 24;341:c6325. doi: 10.1136/bmj.c6325.

3.

A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.

Bellack AS, Bennett ME, Gearon JS, Brown CH, Yang Y.

Arch Gen Psychiatry. 2006 Apr;63(4):426-32.

PMID:
16585472
4.

Achieving effective treatment of patients with chronic psychotic illness and comorbid substance dependence.

Ho AP, Tsuang JW, Liberman RP, Wang R, Wilkins JN, Eckman TA, Shaner AL.

Am J Psychiatry. 1999 Nov;156(11):1765-70.

PMID:
10553741
5.

Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18-month outcomes of a randomised controlled trial.

Haddock G, Barrowclough C, Tarrier N, Moring J, O'Brien R, Schofield N, Quinn J, Palmer S, Davies L, Lowens I, McGovern J, Lewis S.

Br J Psychiatry. 2003 Nov;183:418-26.

PMID:
14594917
6.

Using measures of readiness to change in individuals with schizophrenia.

Addington J, el-Guebaly N, Duchak V, Hodgins D.

Am J Drug Alcohol Abuse. 1999 Feb;25(1):151-61.

PMID:
10078983
7.

Novelty-seeking among schizophrenia patients with comorbid alcohol abuse.

Kim JH, Kim D, Park SH, Lee HB, Chung EK.

J Nerv Ment Dis. 2007 Jul;195(7):622-4.

PMID:
17632255
8.

Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.

Baker KD, Lubman DI, Cosgrave EM, Killackey EJ, Yuen HP, Hides L, Baksheev GN, Buckby JA, Yung AR.

Aust N Z J Psychiatry. 2007 Nov;41(11):896-902.

PMID:
17924242
9.

Effects of motivational interviewing-based adherence therapy for schizophrenia spectrum disorders: a randomized controlled trial.

Chien WT, Mui JH, Cheung EF, Gray R.

Trials. 2015 Jun 14;16:270. doi: 10.1186/s13063-015-0785-z.

10.

Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent-onset schizophrenia: a randomized controlled trial.

Smeerdijk M, Keet R, Dekker N, van Raaij B, Krikke M, Koeter M, de Haan L, Barrowclough C, Schippers G, Linszen D.

Psychol Med. 2012 Aug;42(8):1627-36. doi: 10.1017/S0033291711002832. Epub 2011 Dec 8.

PMID:
22152121
11.

An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.

Maneesakorn S, Robson D, Gournay K, Gray R.

J Clin Nurs. 2007 Jul;16(7):1302-12.

PMID:
17584349
12.

Dual diagnosis and psychosocial interventions--introduction and commentary.

Thylstrup B, Johansen KS.

Nord J Psychiatry. 2009;63(3):202-8. doi: 10.1080/08039480802571069. Review.

PMID:
19034725
13.
14.

Integrated motivational interviewing and cognitive-behavioural therapy for bipolar disorder with comorbid substance use.

Jones SH, Barrowclough C, Allott R, Day C, Earnshaw P, Wilson I.

Clin Psychol Psychother. 2011 Sep-Oct;18(5):426-37. doi: 10.1002/cpp.783. Epub 2011 Sep 6.

PMID:
21898672
15.

Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.

Grant PM, Huh GA, Perivoliotis D, Stolar NM, Beck AT.

Arch Gen Psychiatry. 2012 Feb;69(2):121-7. doi: 10.1001/archgenpsychiatry.2011.129. Epub 2011 Oct 3.

PMID:
21969420
16.

Motivational interviewing among psychiatric in-patients with substance use disorders.

Baker A, Lewin T, Reichler H, Clancy R, Carr V, Garrett R, Sly K, Devir H, Terry M.

Acta Psychiatr Scand. 2002 Sep;106(3):233-40.

PMID:
12197863
17.

Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.

Brunette MF, Noordsy DL, Xie H, Drake RE.

Psychiatr Serv. 2003 Oct;54(10):1395-401.

PMID:
14557527
18.

Behavioral interventions for dual-diagnosis patients.

Goldsmith RJ, Garlapati V.

Psychiatr Clin North Am. 2004 Dec;27(4):709-25. Review.

PMID:
15550289
19.

Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: a randomized controlled trial of clinical efficacy.

Kay-Lambkin FJ, Baker AL, Lewin TJ, Carr VJ.

Addiction. 2009 Mar;104(3):378-88. doi: 10.1111/j.1360-0443.2008.02444.x.

PMID:
19207345
20.

Psychiatric comorbidity in first episode schizophrenia: a 2 year, longitudinal outcome study.

Sim K, Chua TH, Chan YH, Mahendran R, Chong SA.

J Psychiatr Res. 2006 Oct;40(7):656-63. Epub 2006 Aug 14.

PMID:
16904688

Supplemental Content

Support Center